Detection of early-stage lung adenocarcinoma using a novel extracellular vesicle and particle-based blood test

Lung Cancer

Clinical utility of molecular residual disease detection in early-stage resected EGFR-mutated non-small cell lung cancer

Nat Commun

Zhou F, Su C, Liang W, Xu LD, Tao W, Qian J, Xu S, Liu D, Fan R, Zhang Y, Liu Y, Wu L, Fu X, Zhang X, Shen N, Ge D, Chen Q, Mao W, Xu L, Chen C, Hu B, Shao G, Hu J, Zhao J, Liu X, Liu Z, Wang Z, Xiao Z, Gong T, Lin W, Li X, Ye F, Liu Y, Ma H, Huang Y, Zhou J, Wang Z, Fu J, Ding L, Mao L, Chen W, He J, Zhou C

doi: 10.1038/s41467-026-76392-9

Lung Cancer

Lymphatic Invasion Acts as a 'Hidden Risk Factor': Four-Fold Increased Mortality Risk in Early-Stage (TNM Stage I, N0) Non-Small Cell Lung Cancer

J Clin Med

Özer KB, Erus S, Cesur E, Güzey Ö, Bulutay P, Tanju S, Fırat P, Dilege Ş

doi: 10.3390/jcm15124582

Lung Cancer

Clinical Efficacy and Safety of Icotinib as Adjuvant Therapy for Resected Stage IA Lung Adenocarcinoma: A Real-world Study

Clin Lung Cancer

Luo SS, Zhong LQ, Liu X, Li SN, Zhang X, Ao Y, Yang H, Hu Y

doi: 10.1016/j.cllc.2026.07.006

Lung Cancer

Tumor-Agnostic Circulating Tumor DNA Analysis as a Comprehensive Predictive Biomarker of Recurrence after Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer

Clin Lung Cancer

Nakamura M, Kageyama SI, Hirata H, Ohira M, Sakai SA, Hakozaki Y, Hojo H, Fujisawa T, Yamashita R, Haeno H, Kanai A, Suzuki Y, Yamaguchi M, Tsuchihara K, Zenda S

doi: 10.1016/j.cllc.2025.09.013

Lung Cancer

Disease characteristics and treatment outcomes in patients with resected early-stage ALK-positive non-small cell lung cancer from the randomized ALINA trial

Lung Cancer

Barlesi F, Ahn JS, Solomon BJ, Nishio M, Dziadziuszko R, Lee DH, Lee JS, Zhong W, Horinouchi H, Mao W, Hochmair M, de Marinis F, Migliorino MR, Bondarenko I, Xu T, Bara I, Ding B, Ngiam C, Petric P, Wu YL

doi: 10.1016/j.lungcan.2026.109385

Lung Cancer

Assessing Guideline-Directed Care in the New Era of Neoadjuvant Therapy in Early-Stage Resectable Non-small Cell Lung Cancer (NSCLC): A Retrospective Review

Clin Lung Cancer

Maity AP, Kjelstrom S, Gu H, Sanborn M, Kalola A, Savior D, Ghaneie A, Dessain SK

doi: 10.1016/j.cllc.2026.08.004

Lung Cancer

Frequent RBM10 Comutation and a Mutually Exclusive Relationship With Other TP53 Pathway Aberrations in Early-Stage Non-Small-Cell Lung Cancer with EGFR Mutation

Clin Lung Cancer

Suda K, Sakai K, Ito M, Oiki H, Fukuda S, Ohara S, Hamada A, Chiba M, Shimoji M, Nishio K, Tsutani Y

doi: 10.1016/j.cllc.2026.03.002

Lung Cancer

Why are patients with non-small cell lung cancer in stage I-IIIA considered inoperable? A registry-based study from the capital region of Denmark

Eur J Cancer

Budolfsen T, Petersen RH, Møller LB, Brabrand J, Saghir Z, Quist M

doi: 10.1016/j.ejca.2026.116246

Lung Cancer

Real-World Treatment Patterns and Clinical Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy and ≥ 2 Subsequent Lines of Therapy in the United States

Adv Ther

Sankar K, Unni S, Eberl M, Le H, Herrmann T, Gorsh B, Tang M, Coerts F, Ahmed S

doi: 10.1007/s12325-025-03408-z

Related content

Clinical utility of molecular residual disease detection in early-stage resected EGFR-mutated non-small cell lung cancer

Lymphatic Invasion Acts as a 'Hidden Risk Factor': Four-Fold Increased Mortality Risk in Early-Stage (TNM Stage I, N0) Non-Small Cell Lung Cancer

Clinical Efficacy and Safety of Icotinib as Adjuvant Therapy for Resected Stage IA Lung Adenocarcinoma: A Real-world Study

Tumor-Agnostic Circulating Tumor DNA Analysis as a Comprehensive Predictive Biomarker of Recurrence after Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer

Disease characteristics and treatment outcomes in patients with resected early-stage ALK-positive non-small cell lung cancer from the randomized ALINA trial

Assessing Guideline-Directed Care in the New Era of Neoadjuvant Therapy in Early-Stage Resectable Non-small Cell Lung Cancer (NSCLC): A Retrospective Review

Frequent RBM10 Comutation and a Mutually Exclusive Relationship With Other TP53 Pathway Aberrations in Early-Stage Non-Small-Cell Lung Cancer with EGFR Mutation

Why are patients with non-small cell lung cancer in stage I-IIIA considered inoperable? A registry-based study from the capital region of Denmark

Real-World Treatment Patterns and Clinical Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy and ≥ 2 Subsequent Lines of Therapy in the United States